BR112014012407A2 - amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas - Google Patents
amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativasInfo
- Publication number
- BR112014012407A2 BR112014012407A2 BR112014012407A BR112014012407A BR112014012407A2 BR 112014012407 A2 BR112014012407 A2 BR 112014012407A2 BR 112014012407 A BR112014012407 A BR 112014012407A BR 112014012407 A BR112014012407 A BR 112014012407A BR 112014012407 A2 BR112014012407 A2 BR 112014012407A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- proliferative properties
- analogs exhibiting
- pyridone amides
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Abstract
resumo amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas os compostos úteis no tratamento de câncer de mamíferos e especialmente cânceres humanos de acordo com a fórmula i são revelados. as composições e métodos de tratamento empregando os compostos farmacêuticos aqui revelados são também revelados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161562602P | 2011-11-22 | 2011-11-22 | |
PCT/US2012/066237 WO2013078295A2 (en) | 2011-11-22 | 2012-11-21 | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014012407A2 true BR112014012407A2 (pt) | 2017-06-06 |
Family
ID=48470416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014012407A BR112014012407A2 (pt) | 2011-11-22 | 2012-11-21 | amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas |
Country Status (15)
Country | Link |
---|---|
US (2) | US8921565B2 (pt) |
EP (1) | EP2782577A4 (pt) |
JP (1) | JP2015507606A (pt) |
KR (1) | KR20140097402A (pt) |
CN (1) | CN104302292A (pt) |
AU (1) | AU2012327190B2 (pt) |
BR (1) | BR112014012407A2 (pt) |
CA (1) | CA2855980A1 (pt) |
HK (1) | HK1202450A1 (pt) |
IL (1) | IL232647A0 (pt) |
MX (1) | MX2014006126A (pt) |
PH (1) | PH12014501121A1 (pt) |
RU (1) | RU2014125230A (pt) |
SG (1) | SG11201402531XA (pt) |
WO (1) | WO2013078295A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140097402A (ko) * | 2011-11-22 | 2014-08-06 | 데시페라 파마슈티칼스, 엘엘씨. | 항암 및 항증식 활성을 나타내는 피리돈 아미드 및 유사체 |
US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
EP2879677B1 (en) | 2012-07-28 | 2017-06-14 | Calitor Sciences, LLC | Substituted pyrazolone compounds and methods of use |
US8975282B2 (en) | 2012-07-28 | 2015-03-10 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrazolone compounds and methods of use |
CN106659765B (zh) | 2014-04-04 | 2021-08-13 | 德玛医药 | 二脱水半乳糖醇及其类似物或衍生物用于治疗非小细胞肺癌和卵巢癌的用途 |
DK3902547T3 (da) | 2018-12-28 | 2023-12-18 | Deciphera Pharmaceuticals Llc | Csf1r-hæmmere til anvendelse i cancerbehandling |
US20220119425A1 (en) * | 2019-01-15 | 2022-04-21 | The Translational Genomics Research Institute | Phosphonate conjugates and uses thereof |
EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
LT3966206T (lt) | 2019-05-10 | 2023-11-10 | Deciphera Pharmaceuticals, Llc | Heteroarilaminopirimidino amido autofagijos inhibitoriai ir jų naudojimo būdai |
JP7293404B2 (ja) * | 2019-05-24 | 2023-06-19 | メッドシャイン ディスカバリー インコーポレイテッド | c-MET/AXL阻害剤の結晶形 |
EP3983081A1 (en) | 2019-06-17 | 2022-04-20 | Deciphera Pharmaceuticals, LLC | Aminopyrimidine amide autophagy inhibitors and methods of use thereof |
WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
MX2022001863A (es) | 2019-08-12 | 2022-05-30 | Deciphera Pharmaceuticals Llc | Metodos para tratar los tumores del estroma gastrointestinal. |
RS65058B1 (sr) | 2019-12-30 | 2024-02-29 | Deciphera Pharmaceuticals Llc | Formulacije inhibitora amorfne kinaze i postupci njihove primene |
BR112022013169A2 (pt) | 2019-12-30 | 2022-09-13 | Deciphera Pharmaceuticals Llc | Composições de 1-(4-bromo-5-(1-etil-7-(metilamino)-2-oxo-1,2-diidro-1,6-naftiridin-3-il)-2-fluorofeil)-3-fenilurea |
US11912668B2 (en) | 2020-11-18 | 2024-02-27 | Deciphera Pharmaceuticals, Llc | GCN2 and perk kinase inhibitors and methods of use thereof |
WO2023114809A1 (en) | 2021-12-16 | 2023-06-22 | Kinnate Biopharma Inc. | Inhibitors of met kinase |
US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
CN116283920B (zh) * | 2023-03-31 | 2024-04-16 | 贵州医科大学 | 2,4-二取代吡啶类化合物及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5491237A (en) | 1994-05-03 | 1996-02-13 | Glaxo Wellcome Inc. | Intermediates in pharmaceutical camptothecin preparation |
US7459562B2 (en) * | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
PT2089364E (pt) * | 2006-11-08 | 2013-08-26 | Bristol Myers Squibb Co | Compostos de piridinona |
ES2531396T3 (es) | 2008-01-23 | 2015-03-13 | Bristol Myers Squibb Co | Proceso para preparar compuestos de piridinona |
WO2009111529A2 (en) * | 2008-03-04 | 2009-09-11 | Children's Medical Center Corporation | Method of treating polycystic kidney disease |
CN102140093A (zh) * | 2010-02-03 | 2011-08-03 | 上海源力生物技术有限公司 | 吡啶酮酰胺类衍生物、其制备方法及其在医药上的应用 |
EP2563773A1 (en) * | 2010-04-29 | 2013-03-06 | Deciphera Pharmaceuticals, LLC | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites |
KR20140097402A (ko) * | 2011-11-22 | 2014-08-06 | 데시페라 파마슈티칼스, 엘엘씨. | 항암 및 항증식 활성을 나타내는 피리돈 아미드 및 유사체 |
-
2012
- 2012-11-21 KR KR1020147016612A patent/KR20140097402A/ko not_active Application Discontinuation
- 2012-11-21 RU RU2014125230/10A patent/RU2014125230A/ru not_active Application Discontinuation
- 2012-11-21 WO PCT/US2012/066237 patent/WO2013078295A2/en active Application Filing
- 2012-11-21 CN CN201280067610.2A patent/CN104302292A/zh active Pending
- 2012-11-21 AU AU2012327190A patent/AU2012327190B2/en not_active Ceased
- 2012-11-21 BR BR112014012407A patent/BR112014012407A2/pt not_active IP Right Cessation
- 2012-11-21 US US13/683,277 patent/US8921565B2/en not_active Expired - Fee Related
- 2012-11-21 MX MX2014006126A patent/MX2014006126A/es not_active Application Discontinuation
- 2012-11-21 JP JP2014543553A patent/JP2015507606A/ja active Pending
- 2012-11-21 EP EP12851633.3A patent/EP2782577A4/en not_active Withdrawn
- 2012-11-21 CA CA2855980A patent/CA2855980A1/en not_active Abandoned
- 2012-11-21 SG SG11201402531XA patent/SG11201402531XA/en unknown
-
2014
- 2014-05-15 IL IL232647A patent/IL232647A0/en unknown
- 2014-05-19 PH PH12014501121A patent/PH12014501121A1/en unknown
- 2014-11-20 US US14/549,125 patent/US9387202B2/en not_active Expired - Fee Related
-
2015
- 2015-03-30 HK HK15103171.8A patent/HK1202450A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013078295A2 (en) | 2013-05-30 |
RU2014125230A (ru) | 2015-12-27 |
AU2012327190A1 (en) | 2013-06-06 |
KR20140097402A (ko) | 2014-08-06 |
IL232647A0 (en) | 2014-06-30 |
JP2015507606A (ja) | 2015-03-12 |
US20150148380A1 (en) | 2015-05-28 |
HK1202450A1 (en) | 2015-10-02 |
US8921565B2 (en) | 2014-12-30 |
PH12014501121A1 (en) | 2014-08-04 |
US9387202B2 (en) | 2016-07-12 |
CA2855980A1 (en) | 2013-05-30 |
US20130317066A1 (en) | 2013-11-28 |
AU2012327190B2 (en) | 2015-12-24 |
CN104302292A (zh) | 2015-01-21 |
MX2014006126A (es) | 2015-03-19 |
SG11201402531XA (en) | 2014-08-28 |
EP2782577A2 (en) | 2014-10-01 |
EP2782577A4 (en) | 2015-11-11 |
WO2013078295A3 (en) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014012407A2 (pt) | amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas | |
CY1119143T1 (el) | Διεργασια για την παρασκευη παραγωγων και ενδιαμεσων καρβαμουλοπυριδονης | |
TN2015000250A1 (en) | Novel benzimidazole derivatives as ep4 antagonists | |
CY1117183T1 (el) | Διακλαδισμενα παραγωγα 3-φαινυλοπροπιονικου οξεος και η χρηση τους | |
PE20150627A1 (es) | Derivados de c17-alcandiilo y alquendiilo del acido oleanolico y sus metodos de uso | |
PH12014501229A1 (en) | Antibody-drug conjugates and related compounds, compositions, and methods | |
IN2015DN01119A (pt) | ||
EA201390381A1 (ru) | Триазиноксадиазолы | |
IN2014MN02598A (pt) | ||
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
IN2014KN01075A (pt) | ||
UA114656C2 (uk) | Похідні піридину | |
PH12015500746A1 (en) | Benzamides | |
MX353299B (es) | Metodos y composiciones relacionadas con p62 para el tratamiento y profilaxis del cancer. | |
EA201201658A1 (ru) | Производные пиперидина и их применение для лечения метаболических нарушений | |
MY186547A (en) | 4?-fluoro-2?-methyl substituted nucleoside derivatives | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
UY34314A (es) | Derivados de anilina, su preparación y su aplicación terapéutica. | |
PH12015500585A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
MX347541B (es) | Analogos de acido sialico. | |
UA109804C2 (xx) | 2-метоксипіридин-4-ільні похідні | |
EA201400786A1 (ru) | Карбоциклические нуклеозиды, их фармацевтическое применение и композиции | |
UA104197C2 (uk) | 2-АЛК(АЦИЛ)ОКСІ-4-ОКСО-3-ФЕНІЛ-5-R-6-R'-ТІЄНО[2,3-d]ПІРИМІДИНИ, ЯКІ ВИЯВЛЯЮТЬ ДІУРЕТИЧНУ АКТИВНІСТЬ | |
UA111139C2 (uk) | Тверді фармацевтичні композиції і способи їхнього отримання |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |